IPCure is a pioneering biotech start-up dedicated to developing innovative treatments for neurodegenerative, metabolic, and inflammatory diseases. Our mission is to enhance the quality of life for patients worldwide by delivering groundbreaking treatments and paving the way towards curing these diseases.
IPCURE's expertise lies in targeting individual caspases to develop solutions addressing neurodegenerative and inflammatory diseases.
Through cutting-edge research and drug design, we aim to selectively target individual caspases, especially Caspase-2, to create effective therapeutic solutions. Our Flagship drug candidate targets Caspase-2, a crucial enzyme in memory function, to revolutionize the treatment of Frontotemporal Dementia (FTD) and Alzheimer's Disease (AD).
Company Details
- Employees
- 3
- Founded
- -
- Address
- Urgent Healthcare Needs.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.ipcure.life
Ipcure Questions
Ipcure's website is https://www.ipcure.life
Ipcure's LinkedIn profile is https://www.linkedin.com/company/ipcure-biotech
Ipcure has
3 employees.
View email and phone details for 3
employees at Ipcure.
Ipcure's industry is
Biotechnology Research
Ipcure's top competitors are
Pharmaradio,
Era Consulting,
Biomimx® Srl,
Neuromics,
Skin Cafeine (Ex-Mon Beauty Coach),
Spikimm,
Ablevia Biotech Gmbh,
Proskope,
Anchor Orthopedics,
Mitologics.
Ipcure's categories are Biotechnology Research
Ipcure's founding year is 2023
